Results 151 to 160 of about 121,521 (304)
Abstract Background Due to the high frequency of laminitis reported for both conditions, the relationship between pituitary pars intermedia dysfunction (PPID) and insulin dysregulation (ID), and the potential role of dopamine in modifying insulin secretion, requires further investigation.
Nicolas C. Galinelli+7 more
wiley +1 more source
Athan Spiros1, Robert Carr1, Hugo Geerts1,21In Silico Biosciences, Berwyn, PA, USA; 2School of Medicine, University of Pennsylvania, PA, USAAbstract: Species differences in physiology and unique active human metabolites contribute to the limited ...
Athan Spiros, Robert Carr, Hugo Geerts
doaj
Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration. [PDF]
Peng H, Yu S, Zhang Y, Yin Y, Zhou J.
europepmc +1 more source
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. [PDF]
Sergi Ferré+4 more
openalex +1 more source
Abstract Up to 45% of patients with Parkinson's disease (PD) experience impulse control disorders (ICDs), characterized by a loss of voluntary control over impulses, drives or temptations. This study aimed to investigate whether previously identified genetic and psychiatric risk factors interact towards the development of ICDs in PD.
Emma Whooley+4 more
wiley +1 more source
The Role of Dopamine Receptor D2 in Bridging the Intention-Behavior Gap in Sport Participation. [PDF]
Park S+5 more
europepmc +1 more source
Site-directed mutagenesis of the human dopamine D2 receptor [PDF]
Alfred Mansour+5 more
openalex +1 more source
ABSTRACT Background Despite the aetiology of awake bruxism (AB) being prevalently linked to psychological factors, several studies suggested that the use of certain substances, such as tobacco smoking, can contribute to the increase in masticatory muscle activities (MMA) during wakefulness.
Ovidiu Ionut Saracutu+4 more
wiley +1 more source
Accelerating Discovery of Novel and Bioactive Ligands With Pharmacophore-Informed Generative Models [PDF]
Deep generative models have gained significant advancements to accelerate drug discovery by generating bioactive chemicals against desired targets. Nevertheless, most generated compounds that have been validated for potent bioactivity often exhibit structural novelty levels that fall short of satisfaction, thereby providing limited inspiration to human
arxiv